Metastases from non-genital sites comprise about one in six of our malignant ovarian tumors. The mean age of our 24 patients with such metastases was 43.1 years and 81% had bilateral ovarian metastases. Out of the 24 patients we studied, 21 had a gastric primary. The overall survival rate was 41.7% in 6 months, 25.0% in 1 year and 12.5% in 2 years. Patients with no extraovarian metastases had a survival rate of 75.0% at 6 moths, 62.5% at 1 year and 25.0% at 2 years after operation.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Hale RW (1968) Krukenberg tumor of the ovaries: a review of 81 records. Obstet Gynecol 32: 221–225
Israel SL, Helsel EW jr, Hausman DH (1965) The challenge of metastatic ovarian carciroma. Am J Obstet Gynecol 93: 1094–1101
Johansson H (1960) Clinical aspects of metastatic ovarian cancer of extragenital origin. Acta Obst Gynecol Scand 39: 681–697
About this article
Cite this article
Shiromizu, K., Kawana, T., Sugase, M. et al. Experience with the treatment of metastatic ovarian carcinoma. Arch Gynecol Obstet 243, 111–114 (1988). https://doi.org/10.1007/BF00932977
- Metastatic ovarian carcinoma
- Extraovarian spread